Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Potential interaction between warfarin and boldo-fenugreek.

Lambert JP, Cormier J.

Pharmacotherapy. 2001 Apr;21(4):509-12.

PMID:
11310527
2.
3.

Warfarin and acetaminophen interaction.

Gebauer MG, Nyfort-Hansen K, Henschke PJ, Gallus AS.

Pharmacotherapy. 2003 Jan;23(1):109-12.

PMID:
12523469
4.

Interaction of fluvoxamine with warfarin in an elderly woman.

Yap KB, Low ST.

Singapore Med J. 1999 Jul;40(7):480-2.

PMID:
10560276
5.

Interaction between gemfibrozil and warfarin: case report and review of the literature.

Dixon DL, Williams VG.

Pharmacotherapy. 2009 Jun;29(6):744-8. doi: 10.1592/phco.29.6.744. Review.

PMID:
19476425
6.
7.

Leflunomide and warfarin interaction: case report and review of the literature.

Chonlahan J, Halloran MA, Hammonds A.

Pharmacotherapy. 2006 Jun;26(6):868-71. Review.

PMID:
16716139
8.

Potentiation of warfarin by dong quai.

Page RL 2nd, Lawrence JD.

Pharmacotherapy. 1999 Jul;19(7):870-6.

PMID:
10417036
9.

Probable warfarin interaction with menthol cough drops.

Coderre K, Faria C, Dyer E.

Pharmacotherapy. 2010 Jan;30(1):110. doi: 10.1592/phco.30.1.110.

PMID:
20030479
10.

Interaction between warfarin and cranberry juice.

Paeng CH, Sprague M, Jackevicius CA.

Clin Ther. 2007 Aug;29(8):1730-5.

PMID:
17919554
11.

Cranberry and warfarin interaction: a case report and review of the literature.

Haber SL, Cauthon KA, Raney EC.

Consult Pharm. 2012 Jan;27(1):58-65. doi: 10.4140/TCP.n.2012.58. Review.

PMID:
22231999
12.

Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.

DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.

Pharmacotherapy. 2007 May;27(5):691-6.

PMID:
17461704
13.

Potential interaction between clarithromycin and warfarin.

Recker MW, Kier KL.

Ann Pharmacother. 1997 Sep;31(9):996-8.

PMID:
9296238
14.

The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation.

Howard PA, Ellerbeck EF, Engelman KK, Patterson KL.

Pharmacoepidemiol Drug Saf. 2002 Oct-Nov;11(7):569-76.

PMID:
12462133
15.

Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.

Sellam J, Costedoat-Chalumeau N, Amoura Z, Aymard G, Choquet S, Trad S, Vignes BL, Hulot JS, Berenbaum F, Lechat P, Cacoub P, Ankri A, Mariette X, Leblond V, Piette JC.

Joint Bone Spine. 2007 Oct;74(5):446-52. Epub 2007 Jul 6.

PMID:
17692552
16.

Knowledges about herbal products among subjects on warfarin therapy and patient-physician relationship: a pilot study.

Cuzzolin L, Francini-Pesenti F, Zaffani S, Brocadello F, Pengo V, Bassi A, Benoni G.

Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):1014-7.

PMID:
17615601
17.

Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy.

Le AT, Hasson NK, Lum BL.

Ann Pharmacother. 1997 Sep;31(9):1006-8.

PMID:
9296241
18.

Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control.

Morgan CL, McEwan P, Tukiendorf A, Robinson PA, Clemens A, Plumb JM.

Thromb Res. 2009 May;124(1):37-41. doi: 10.1016/j.thromres.2008.09.016. Epub 2008 Dec 4.

PMID:
19062079
19.

Probable interaction between warfarin and marijuana smoking.

Yamreudeewong W, Wong HK, Brausch LM, Pulley KR.

Ann Pharmacother. 2009 Jul;43(7):1347-53. doi: 10.1345/aph.1M064. Epub 2009 Jun 16.

PMID:
19531696
20.

Probable warfarin-simvastatin interaction.

Westergren T, Johansson P, Molden E.

Ann Pharmacother. 2007 Jul;41(7):1292-5. Epub 2007 Jun 12.

PMID:
17565042

Supplemental Content

Support Center